Who is behind this
About Peptide Sport
An independent, evidence-first guide to peptide therapy — and to the telehealth market that sells it.
Why this site exists
Most of what is written about peptides is written by someone selling them. The result is a field where a rodent study becomes “clinically proven”, a mechanism becomes a result, a monthly price turns out to be a prepay rate, and the one fact a drug-tested athlete actually needs — that most of these compounds are banned in tested sport, year-round, prescription or not — is left off the page entirely. Peptide Sport exists to do the boring version of that work properly: read the primary research, say plainly what has been shown in humans and what has only been shown in mice, and check the prices against the seller's own page rather than repeating them.
What we cover
Peptide therapy broadly, not one compound. That means the recovery and growth-hormone peptides this site started with — BPC-157, TB-500, sermorelin, ipamorelin, CJC-1295, tesamorelin, MK-677 — and equally the GLP-1 drugs that are themselves peptides, NAD+, the metabolic and cognitive compounds, and the growth factors people reach for when the others disappoint them. Because the same telehealth clinics increasingly sell peptides, GLP-1s and hormone programs side by side, the providers are in scope too: we review them, price them, and rank them. Across 139 guides the treatment is the same regardless of which of those a compound belongs to — the evidence is graded on what exists, not on how well it sells.
Who writes it
Derek Olsson is Peptide Sport's sports science editor, writing about recovery, performance, and the peptides athletes actually ask about. Every claim is tied to primary research. The brief runs across the whole field this site covers — recovery and growth-hormone peptides, the GLP-1 drugs, the metabolic and cognitive compounds, and the clinics selling all of them. The job is narrower than it sounds and mostly unglamorous: find the actual trial, read what it measured, work out whether the outcome anyone cares about was measured at all, and write down the answer even when the answer is “nobody has tested this”. Nothing on this site is written by a company that sells what it describes, and no external party contributes copy.
How the work is done
Every factual claim is tied to a primary source — a peer-reviewed study or official FDA labeling — cited in the piece, with animal and mechanism data labeled separately from anything shown in people. Every provider price was read off that provider's own public page on a date we record, and “pricing not published” is printed as the finding rather than filled in with an estimate. Affiliate partners are placed first on our ranked lists, which is a commercial position we disclose rather than disguise — the assessment printed beside each one is what a commission cannot buy. The full method, including how we handle being wrong, is on the editorial policy page, and the money is set out in full on how we earn.
Corrections and contact
A source we missed, a price that has moved, a claim you think is wrong — send it. Email reach@peptidesport.com. We read everything, we fix what needs fixing, and the piece's updated date moves when we do. Nothing here is medical advice — see the medical disclaimer and talk to a licensed clinician before starting anything.